by John Conrad | Mar 20, 2020 | COVID, Member News
Originally posted on CSL Behring’s WebsiteOriginally posted on CSL Behring’s Website As coronavirus (COVID-19) cases mount, global biotech leader CSL has formally offered to help governments around the world by lending its expertise, technologies and facilities to...
by John Conrad | Mar 20, 2020 | COVID, iBIO News
The Illinois Life Sciences Community is leading the charge in the fight against COVID-19. iBIO members have stepped up to develop potential therapeutics and diagnostics for the disease. To stay up-to-date on our members current efforts and the progression of...
by John Conrad | Mar 19, 2020 | COVID, COVIDFDA
In response to growing difficulties companies are expecting to face running trials, the Food and Drug Administration has issued a new guidance to help navigate the problems. Considerations for ongoing trials: Ensuring the safety of trial participants is paramount....
by John Conrad | Mar 19, 2020 | COVID, Member News
Abbott (NYSE: ABT) announced today that the U.S. Food and Drug Administration has issued Emergency Use Authorization (EUA) for the company’s molecular test for novel coronavirus (COVID-19). Abbott is immediately shipping 150,000 Abbott RealTime SARS-CoV-2 EUA...
by John Conrad | Mar 16, 2020 | COVID
Thu, Mar 19, 2020 2:00 PM EDT (1:00 PM CDT) RSVP Webinar by: McDermott Will & Emery. As the globe grapples with increasing challenges to sustaining “business as usual” in their enterprises, our team of Employment, Employee Benefits, Health and Privacy &...
